Research programme: mu opioid receptor agonists - Medifron
Latest Information Update: 13 Jul 2022
At a glance
- Originator Medifron DBT
- Class Analgesics
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Neuropathic pain
Most Recent Events
- 16 Jun 2022 Early research in Neuropathic pain in South Korea (unspecified route)